Biopharmaceutical company.
Active 2020–2022. The register lists this client once for every firm that files on its behalf; all 2 of its records are shown together here.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2022 | MORPHOSYS US INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination (No Activity) |
— | |
| 2021 | TIBER CREEK GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination (No Activity) |
$30,000 | |
| 2021 | MORPHOSYS US INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | |
| 2021 | MORPHOSYS US INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
— | |
| 2021 | TIBER CREEK GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
$30,000 | |
| 2021 | MORPHOSYS US INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | |
| 2021 | TIBER CREEK GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
$30,000 | |
| 2021 | MORPHOSYS US INC. |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | |
| 2021 | MORPHOSYS US INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
— | |
| 2021 | TIBER CREEK GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
$10,000 |
| Firm | Filings | Amount |
|---|---|---|
| TIBER CREEK GROUP | 5 | $100,000 |
| MORPHOSYS US INC. IN-HOUSE | 11 | — |
| Issue | Activities |
|---|---|
| Health Issues | 1 |
| Pharmacy | 1 |